Table 6.6e

Immunosuppression Use for Maintenance

Prior to Discharge, 1995 to 2004

Recipients with Pancreas Transplant Alone (PTA) Transplants

  Year of Transplant
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Functioning Graft at Discharge 37 44 67 73 125 114 149 164 143 172
With Immunosuppression Info 36 42 66 66 123 112 142 151 117 159
Corticosteroids Any in Category 25.0% 81.0% 95.5% 97.0% 71.5% 82.1% 81.7% 75.5% 61.5% 50.3%
Steroids 25.0% 81.0% 95.5% 97.0% 71.5% 82.1% 81.7% 75.5% 61.5% 50.3%
Cyclosporine Any in Category 36.1% 14.3% 9.1% 6.1% 2.4% 4.5% 4.2% 4.0% 2.6% 1.3%
Cyclosporin 27.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Sandimmmune 0.0% 2.4% 4.5% 1.5% 0.0% 0.0% 1.4% 0.0% 0.0% 0.0%
Neoral 8.3% 11.9% 4.5% 4.5% 2.4% 4.5% 2.8% 4.0% 2.6% 1.3%
Tacrolimus Any in Category 58.3% 83.3% 84.8% 92.4% 95.1% 92.0% 94.4% 94.7% 80.3% 74.2%
Tacrolimus 58.3% 83.3% 84.8% 92.4% 95.1% 92.0% 94.4% 94.7% 80.3% 74.2%
Antimetabolites Any in Category 80.6% 95.2% 93.9% 87.9% 64.2% 70.5% 64.8% 65.6% 70.9% 62.9%
Mycophenolate Mofetil 19.4% 81.0% 89.4% 80.3% 64.2% 68.8% 64.1% 64.2% 70.9% 61.6%
Azathioprine 58.3% 14.3% 4.5% 6.1% 0.0% 1.8% 0.7% 1.3% 0.0% 1.3%
Cytoxan 2.8% 0.0% 0.0% 1.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
mTOR Inhibitors Any in Category 0.0% 0.0% 0.0% 0.0% 1.6% 8.0% 11.3% 16.6% 20.5% 11.9%
Sirolimus 0.0% 0.0% 0.0% 0.0% 1.6% 8.0% 11.3% 16.6% 20.5% 11.9%
Everolimus 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%


Source: OPTN/SRTR Data as of May 2, 2005.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients maybe prescribed more than one drug within the same category.